EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

L. E. L. Hendriks*, E. F. Smit, B. A. H. Vosse, W. W. Mellema, D. A. M. Heideman, G. P. Bootsma, M. Westenend, C. Pitz, G. J. de Vries, R. Houben, K. Grunberg, M. Bendek, E-J M. Speel, A-M C. Dingemans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

67 Citations (Web of Science)
1 Downloads (Pure)
Original languageEnglish
Pages (from-to)86-91
JournalLung Cancer
Volume84
Issue number1
DOIs
Publication statusPublished - Apr 2014

Keywords

  • NSCLC
  • EGFR
  • KRAS
  • Brain metastases
  • Bone metastases
  • Survival

Cite this